Search research articles
Contact Us
Filters
Showing results (241-250 of 457) with videos related to
Page
of 46
Sort By:
Leukemia Research
|
August 29, 2022
Comparison between GATA2 and DDX41-mutated myeloid neoplasms
Ahmad Nanaa, Rong He, David Viswanatha, et al.
Blood Advances
|
October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
Ibrahim Aldoss, Jun Yin, Anna Wall, et al.
Haematologica
|
November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Haematologica
|
September 8, 2022
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
Ayalew Tefferi, Amritpal Singh, Naseema Gangat, et al.
American Journal of Hematology
|
March 18, 2022
Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts
Naseema Gangat, Kristen McCullough, Isla Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation
Abhishek Singla, William J Hogan, Stephen M Ansell, et al.
American Journal of Hematology
|
December 15, 2015
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)
Clive S Zent, Xin Victoria Wang, Rhett P Ketterling, et al.
Blood Advances
|
February 18, 2026
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?
Flavia Gava, Bonnie Yates, Zhouxin Sun, et al.
Haematologica
|
March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Page
of 46
Search research articles
Search
Showing results (241-250 of 457) with videos related to
Sort By:
Page
of 46
Leukemia Research
|
August 29, 2022
Comparison between GATA2 and DDX41-mutated myeloid neoplasms
Ahmad Nanaa, Rong He, David Viswanatha, et al.
Blood Advances
|
October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
Ibrahim Aldoss, Jun Yin, Anna Wall, et al.
Haematologica
|
November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Haematologica
|
September 8, 2022
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
Ayalew Tefferi, Amritpal Singh, Naseema Gangat, et al.
American Journal of Hematology
|
March 18, 2022
Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts
Naseema Gangat, Kristen McCullough, Isla Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation
Abhishek Singla, William J Hogan, Stephen M Ansell, et al.
American Journal of Hematology
|
December 15, 2015
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)
Clive S Zent, Xin Victoria Wang, Rhett P Ketterling, et al.
Blood Advances
|
February 18, 2026
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?
Flavia Gava, Bonnie Yates, Zhouxin Sun, et al.
Haematologica
|
March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Page
of 46